Firstly, increased production of several CD4+ T cell-mediated cytokines, including IL-27, IL-6, TGF-β, and IL-17A, was detected in the serum of SSc patients, which may directly drive vascular dysregulation and fibrosis [19, 20]. This evidence concerns the gene CD4 and systemic sclerosis.